Results 231 to 240 of about 177,184 (344)

Characteristics, crack use, housing situation and psychosocial problems of people in the open drug scene in cologne, Germany - results of a cross-sectional survey. [PDF]

Harm Reduct J
Deimel D, Feldmann L, Scherbaum N, Firk C, Fleißner S.   +4 more
europepmc   +1 more source

Deaths from heroin overdose are preventable [PDF]

, 1998
Kamran Abbasi
openalex   +1 more source

Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries

Addiction, Volume 120, Issue 9, Page 1739-1746, September 2025.
Abstract Background and Aims The use of new synthetic opioids, such as the highly potent 2‐benzylbenzimidazoles (i.e. nitazene) drugs, is a global health concern because of their increased risk of fatal overdose. In the early 2020s, nitazene analogues were linked to significant numbers of overdoses in the United States.
Richard Bade, Dhayaalini Nadarajan, Wayne Hall, Jared A. Brown, NPS Wastewater Consortium, Jennifer Schumann, Christine Baduel, Lubertus Bijlsma, Tim Boogaerts, Dan Burgard, Sara Castiglioni, Nicola Ceolotto, Andrew Chappell, Heather Coleman, Ana Flavia Barbosa de Oliveira, Erin M. Driver, Andrea Estévez‐Danta, Fernando Fabriz Sodre, Despo Fatta Kassinos, Harold A Flores Quintana, Cobus Gerber, Emma Gracia‐Lor, Elisa Gracia‐Marín, Rolf U. Halden, Ester Heath, Carolin Huber, Julia Huchthausen, Emma L. Keller, Barbara Kasprzyk‐Hordern, Foon Yin Lai, Arndís Sue‐Ching Löve, Jandyson M. Santos, Herbert Oberacher, Vera Ocenaskova, Jeong‐Eun Oh, Temilola Oluseyi, Kaitlyn Phung, Marco Pineda‐Castro, Magda Psichoudaki, Andressa S. Reis, Francisca Corthorn, Noelia Salgueiro‐Gonzalez, Cezar Silvino‐Gomes, Bikram Subedi, Nikolaos Thomaidis, Aline de Melo Vieira, Degao Wang, Viviane Yargeau   +47 more
wiley   +1 more source

Pharmacokinetics and Pharmacodynamics of Intranasal Diacetylmorphine in Heroin-Assisted Treatment for Severe Opioid Use Disorder. [PDF]

CNS Drugs
Guessoum A, Vogt SB, Meyer M, Westenberg JN, Klemperer B, Dürsteler KM, Liechti ME, Thomann J, Luethi D, Duthaler U, Vogel M.   +10 more
europepmc   +1 more source

Heroin Substitution in Canada: A Necessary Public Health Intervention? [PDF]

, 1997
Ron de Burger
openalex   +1 more source

Post‐treatment life‐trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis

British Journal of Health Psychology, Volume 30, Issue 3, September 2025.
Abstract Background Hepatitis C Virus is a global health burden, particularly affecting people who inject drugs. Direct‐acting antiviral treatment can cure almost all people infected with hepatitis C. However, the longer‐term impacts on within people's life trajectories are unknown, although some suggest it may lead to fundamental behavioural changes ...
Gabriele Vojt, Lawrie Elliott, Hannah Family, Christian Sharkey, Brian Stephens, Sharon Hutchinson, Matt Hickman, John F. Dillon, Magdalena Harris, Paul Flowers   +9 more
wiley   +1 more source

The ‘heroin trial’, abstinence and community expectations [PDF]

, 1995
Gabriele Bammer
openalex   +1 more source

A GLP‐1R/Y1 receptor/Y2 receptor triple agonist decreases fentanyl‐evoked dopamine release in the nucleus accumbens and attenuates fentanyl taking and seeking in rats

British Journal of Pharmacology, Volume 182, Issue 18, Page 4363-4379, September 2025.
Abstract Background and Purpose Emerging literature indicates that simultaneously targeting glucagon‐like peptide‐1 receptors (GLP‐1Rs) and neuropeptide Y receptors (Y1/Y2) may represent a new pharmacotherapeutic approach to treating opioid use disorder (OUD).
Antonia Caffrey, Enzo Lavecchia, Kylie S. Chichura, Matthew R. Hayes, Robert P. Doyle, Heath D. Schmidt   +5 more
wiley   +1 more source

Supervised and unsupervised learning reveal heroin-induced impairments in astrocyte structural plasticity. [PDF]

Sci Adv
Marini M, Niu Y, Zhao H, Mohan A, Koorndyk N, Kruyer A, Labate D.   +6 more
europepmc   +1 more source

Relationships Between Motives for Cannabis and Cannabidiol Use in People Who Co‐Use: Results From the European Web Survey on Drugs

Drug and Alcohol Review, Volume 44, Issue 6, Page 1666-1679, September 2025.
ABSTRACT Introduction Cannabis is one of the most commonly used psychoactive substances globally. Cannabidiol (CBD) is a non‐intoxicating cannabis compound increasingly used for various purposes, especially among cannabis users. However, to date, there are no data on the relationships between cannabis and CBD motives.
Davide Fortin, Vincent Leroy, Patrizia Carrieri, João Matias, Tangui Barré   +4 more
wiley   +1 more source